Top compounds associated with response to EIF2S1


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine gCSI pan-cancer AAC 0.23 5e-05
mRNA CCT018159 GDSC1000 pan-cancer AAC 0.13 0.0001
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA niclosamide CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA Doxorubicin gCSI pan-cancer AAC 0.18 0.0006
mRNA Docetaxel gCSI pan-cancer AAC 0.19 0.0007
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0007
mRNA Irinotecan gCSI pan-cancer AAC 0.18 0.0007
mRNA Topotecan CCLE pan-cancer AAC 0.15 0.0009
mRNA paclitaxel gCSI pan-cancer AAC 0.18 0.001
Download CSV